Invited commentary: Prevailing over acquired immune deficiency syndrome and depressive symptoms

American Journal of Epidemiology

Volumn 177, Issue 2, 2013, Pages 126-128

  Coughlin, Steven S ^a,b  

^a DEPARTMENT OF VETERANS AFFAIRS   (United States)

^b EMORY UNIVERSITY   (United States)

Author keywords

acquired immunodeficiency; comorbidity; depression; poverty; substance abuse; survival; women

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; ANTIDEPRESSANT AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; EPIDEMIOLOGY; LONG-TERM CHANGE; MENTAL HEALTH; MORTALITY; POVERTY; QUALITY OF LIFE; SURVIVAL; SYMPTOM; UNEMPLOYMENT; WOMENS HEALTH;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ALCOHOLISM; ARTICLE; COGNITIVE DEFECT; COMORBIDITY; DEPRESSION; HEALTH BEHAVIOR; HEALTH CARE; HEPATITIS C; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LONG TERM SURVIVAL; MENTAL DISEASE; MIXED INFECTION; MORTALITY; POVERTY; PSYCHOTHERAPY; QUALITY OF LIFE; SEX DIFFERENCE; SEXUAL BEHAVIOR; SMOKING; UNEMPLOYMENT;

ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CAUSE OF DEATH; FEMALE; HIV INFECTIONS; HUMANS; LIFE EXPECTANCY; MALE;

HUMAN IMMUNODEFICIENCY VIRUS;

EID: 84872235128     PISSN: 00029262     EISSN: 14766256     Source Type: Journal    
DOI: 10.1093/aje/kws319     Document Type: Article

References (22)

1. Wada N, Jacobson LP, Cohen M, et al. Cause-specific life expectancies after 35 years of age for HIV-infected and HIVnegative individuals followed simultaneously in long-term cohort studies, 1984-2008. Am J Epidemiol. 2013;177(2): 116-125.
2. Lyketsos CG, Hoover DR, Guccione M, et al. Depressive symptoms as predictors of medical outcomes in HIV infection. Multicenter AIDS Cohort Study. JAMA. 1993; 270(21):2563-2567.
3. Lyketsos CG, Hoover DR, Guccione M, et al. Changes in depressive symptoms as AIDS develops. Am J Psychiatry. 1996;153(11):1430-1437.
4. Farinpour R, Miller EN, Satz P, et al. Psychosocial risk factors of HIV morbidity and mortality: findings from the multicenter AIDS Cohort Study (MACS). J Clin Exp Neuropsychol. 2003;25(5):654-670.
5. Cohen MH, French AL, Benning L, et al. Causes of death among women with human immunodeficiency virus infection in the era of combination antiretroviral therapy. Am J Med. 2002;113(2):91-98.
6. Nurutdinova D, Chrusciel T, Zeringue A, et al. Mental health disorders and the risk of AIDS-defining illness and death in HIV-infected veterans. AIDS. 2012;26(2):229-234.
7. Lima VD, Geller J, Bangsberg DR, et al. The effect of adherence on the association between depressive symptoms and mortality among HIV-infected individuals first initiating HAART. AIDS. 2007;21(9):1175-1183.
8. Pence BW, O'Donnell JK, Gaynes BN. Falling through the cracks: the gaps between depression prevalence, diagnosis, treatment, and response in HIV care. AIDS. 2012;26(5): 656-658.
9. Pence BW. The impact of mental health and traumatic life experiences on antiretroviral treatment outcomes for people living with HIV/AIDS. J Antimicrobiol Chemother. 2009; 63(4):636-640.
10. Sherr L, Clucas C, Harding R, et al. HIV and depression-a systematic review of interventions. Psychol Health Med. 2011;16(5):493-527.
11. Weiser SD, Riley ED, Ragland K, et al. Factors associated with depression among homeless and marginally housed HIV-infected men in San Francisco. J Gen Int Med. 2006; 21(1):61-64.
12. Weaver MR, Conover CJ, Prescholdbell RJ, et al. Utilization of mental health and substance abuse care for people living with HIV/AIDS, chronic mental illness, and substance abuse disorders. J Acquir Immune Defic Syndr. 2008;47(4):449-458.
13. Ickovics JR, Hamburger ME, Vlahov D, et al. Mortality, CD4 cell count decline, and depressive symptoms among HIV-seropositive women. Longitudinal analysis from the HIV Epidemiology Research Study. JAMA. 2001;285(11): 1466-1474.
14. Devlin KN, Gongvatana A, Clark US, et al. Neurocognitive effects of HIV, hepatitis C, and substance use history. J Int Neuropsychol Soc. 2012;18(0):68-78.
15. Parsons TD, Tucker KA, Hall CD, et al. Neurocognitive functioning and HAART in HIV and hepatitis C virus co-infection. AIDS. 2006;20(12):1591-1595.
16. Vivithanaporn P, Neeles K, DeBlock L, et al. Hepatitis C virus co-infection increases neurocognitive impairment severity and risk of death in treated HIV/AIDS. J Neurol Sci. 2012;312(1-2):45-51.
17. Libman H, Saltz R, Nunes D, et al. Hepatitis C infection is associated with depressive symptoms in HIV-infected adults with alcohol problems. Am J Gastroenterol. 2006;101(8): 1804-1810.
18. Prince M, Patel V, Saxena S, et al. No health without mental health. Lancet. 2007;370(9590):859-877.
19. Pappin M, Wouters E, Booysen FL. Anxiety and depression amongst patients enrolled in a public sector antiretroviral treatment programme in South Africa: a cross-sectional study. BMC Public Health. 2012;12:224. (doi: 10.1186/1471-2458-12-244).
20. Schuster R, Bornovalova M, Hunt E. The influence of depression on the progression of HIV: direct and indirect effects. Behav Mod. 2012;36(2):123-145.
21. Nachega JB, Morroni C, Zuniga JM, et al. HIV-related stigma, isolation, discrimination, and serostatus disclosure: a global survey of 2035 HIV-infected adults. J Int Assoc Physicians AIDS Care (Chic). 2012;11(3): 172-178.
22. Andrinopoulos K, Clum G, Murphy DA, et al. Health related quality of life and psychosocial correlates among HIV-infected adolescent and young adult women in the US. AIDS Educ Prev. 2011;23(4):367-381.